Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury
Rabea Hinkel, Deepak Ramanujam, Veronika Kaczmarek, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 15, pp. 1788-1800
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Non-coding RNAs in disease: from mechanisms to therapeutics
Kinga Németh, Recep Bayraktar, Manuela Ferracin, et al.
Nature Reviews Genetics (2023) Vol. 25, Iss. 3, pp. 211-232
Closed Access | Times Cited: 327
MicroRNAs as therapeutic targets in cardiovascular disease
Bernhard Laggerbauer, Stefan Engelhardt
Journal of Clinical Investigation (2022) Vol. 132, Iss. 11
Open Access | Times Cited: 106
MicroRNA-21–Dependent Macrophage-to-Fibroblast Signaling Determines the Cardiac Response to Pressure Overload
Deepak Ramanujam, Anna Patricia Schön, Christina M. Beck, et al.
Circulation (2021) Vol. 143, Iss. 15, pp. 1513-1525
Open Access | Times Cited: 104
MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction
Rui Song, Chiranjib Dasgupta, Cassidy Mulder, et al.
Circulation (2022) Vol. 145, Iss. 15, pp. 1140-1153
Open Access | Times Cited: 86
Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review
Francesco Nappi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3630-3630
Open Access | Times Cited: 29
Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease
Andrea Caporali, Maryam Anwar, Yvan Devaux, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 8, pp. 556-573
Closed Access | Times Cited: 20
Targeted delivery of therapeutic agents to the heart
Susmita Sahoo, Taro Kariya, Kiyotake Ishikawa
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 389-399
Open Access | Times Cited: 102
Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond
Andreas Daiber, Omar Hahad, Ioanna Andreadou, et al.
Redox Biology (2021) Vol. 42, pp. 101875-101875
Open Access | Times Cited: 79
AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction
Rabea Hinkel, Sándor Bátkai, Andrea Bähr, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 23, pp. 2923-2935
Open Access | Times Cited: 58
Small non-coding RNA therapeutics for cardiovascular disease
Ajay M. Shah, Mauro Giacca
European Heart Journal (2022) Vol. 43, Iss. 43, pp. 4548-4561
Open Access | Times Cited: 54
Non-Coding RNAs: Prevention, Diagnosis, and Treatment in Myocardial Ischemia–Reperfusion Injury
Mihnea-Cosmin Marinescu, Andrada-Luciana Lazăr, Monica Mihaela Marta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2728-2728
Open Access | Times Cited: 50
A coalition to heal—the impact of the cardiac microenvironment
Eldad Tzahor, Stefanie Dimmeler
Science (2022) Vol. 377, Iss. 6610
Closed Access | Times Cited: 49
Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine
Ellen S. Smith, Eric Whitty, Byunghee Yoo, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1588-1588
Open Access | Times Cited: 48
Noncoding RNAs in age-related cardiovascular diseases
Amela Jusić, Pınar Buket Thomas, Stephanie Bezzina Wettinger, et al.
Ageing Research Reviews (2022) Vol. 77, pp. 101610-101610
Closed Access | Times Cited: 47
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies
Susana Ravassa, Begoña López, Thomas A. Treibel, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101194-101194
Open Access | Times Cited: 36
Platelet-Derived MicroRNAs Regulate Cardiac Remodeling After Myocardial Ischemia
Jan Philipp Schütte, Mailin-Christin Manke, Katherina Hemmen, et al.
Circulation Research (2023) Vol. 132, Iss. 7
Open Access | Times Cited: 26
Epigenetics as a versatile regulator of fibrosis
Yang Liu, Dongsheng Wen, Chiakang Ho, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Exosomes derived from mir-214-3p overexpressing mesenchymal stem cells promote myocardial repair
Wenwu Zhu, Qingjie Wang, Jian Zhang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development
Timothy A. McKinsey, Roger Foo, Chukwuemeka George Anene-Nzelu, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3482-3498
Open Access | Times Cited: 37
Cardiorenal syndrome: long road between kidney and heart
Carolina Victória Cruz Junho, Mayra Trentin‐Sonoda, Karine Panico, et al.
Heart Failure Reviews (2022) Vol. 27, Iss. 6, pp. 2137-2153
Open Access | Times Cited: 34
MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Redox Control of Cell Senescence
Daniele Lettieri‐Barbato, Katia Aquilano, Carolina Punziano, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 480-480
Open Access | Times Cited: 32
The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments
Anetta Wronska
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 123-132
Open Access | Times Cited: 31
Targeting Interactions between Fibroblasts and Macrophages to Treat Cardiac Fibrosis
Bo Yang, Yan Qiao, Yan Dong, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 764-764
Open Access | Times Cited: 7
Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact
Ida G. Lunde, Karoline Bjarnesdatter Rypdal, Sophie Van Linthout, et al.
Matrix Biology (2024) Vol. 134, pp. 1-22
Closed Access | Times Cited: 7
Inhibition of miR-21: cardioprotective effects in human failing myocardium ex vivo
Naisam Abbas, Jonas A. Haas, Ke Xiao, et al.
European Heart Journal (2024) Vol. 45, Iss. 22, pp. 2016-2018
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top